Exhibit 99.1
| |
|
|
300 Throckmorton Street |
Fort Worth, TX 76102 |
KMG Reports Fourth Quarter and Full Year 2016 Financial Results
FORT WORTH, Texas—(BUSINESS WIRE)—October 13, 2016—KMG (NYSE: KMG), a global provider of specialty chemicals, today announced financial results for the fourth fiscal quarter and fiscal year ended July 31, 2016.
2016 Fourth Quarter Financial Highlights
| · | GAAP diluted earnings per share of $0.31 increased 11% from $0.28 per share in the fourth quarter of fiscal 2015. |
| · | Adjusted diluted earnings per share1 was $0.38 vs. $0.32 per share reported in the fourth quarter of last year. |
| · | GAAP net income was $3.7 million compared to $3.3 million in the prior year period. |
| · | Adjusted EBITDA2 of $11.7 million increased 16% from $10.1 million in the fourth quarter of fiscal 2015. |
2016 Fiscal Year Financial Highlights
| · | GAAP diluted earnings per share was $1.57 vs. $1.03 in fiscal 2015. |
| · | Adjusted diluted earnings per share3 was $1.61 vs. $1.21 per share in the prior year. |
| · | GAAP net income of $18.7 million increased 54% from the prior year. |
| · | Adjusted EBITDA4 of $45.4 million increased 22% from $37.1 million last year. |
| · | Long-term debt balance at year-end was $35.8 million, compared to $53 million at the close of fiscal 2015. During fiscal 2016, the company reduced debt by $20 million and borrowed $2.8 million to acquire Nagase FineChem (NFC). |
Chris Fraser, KMG chairman and chief executive officer, said, “Fiscal 2016 was a very successful year for KMG. We took significant steps toward building an even stronger company by achieving sustainable efficiency improvements and advancing our growth strategy in Asia with the acquisition of NFC. We generated 54% growth in net income to a record $18.7 million and 22% growth in adjusted EBITDA to a record $45.4 million. Additionally, operating cash flow more than doubled to $41 million, representing an all-time high for KMG.
“Despite a decline in global silicon wafer shipments, fiscal 2016 sales in our electronic chemicals segment grew modestly from the prior year, excluding a $6 million foreign currency translation impact from the strengthening of the U.S. dollar. Segment operating income increased nearly 50% for the year to a record $32.1 million, driven by higher product sales and our expanded global presence. We also benefited from continuing manufacturing efficiency and lower distribution costs.
1 Non-U.S. GAAP measure. See Table 2 for reconciliation. |
|
2 | Non-U.S. GAAP measure. See Tables 1 and 1A for reconciliation. |
3 | Non-U.S. GAAP measure. See Table 2 for reconciliation. |
4 | Non-U.S. GAAP measure. See Tables 1 and 1A for reconciliation. |
Phone: 817.761.6100 ● Fax: 817.720.1043
www.kmgchemicals.com ● NYSE: KMG
“Our other chemicals segment delivered strong fiscal 2016 results as well, reporting a 45% year-over-year improvement in operating income, aided by a positive contribution from the industrial lubricants business and improved costs.”
Mr. Fraser continued, “I’m pleased with our 21% year-over-year growth in fourth quarter operating income to $7.1 million, which was fueled in part by continued efficiency enhancements and lower distribution costs. However, our effective tax rate in the fourth quarter was impacted by certain discrete items that raised our tax rate in the period to 42.6%, limiting the growth in earnings per share in the quarter.”
Mr. Fraser concluded, “Currently we are experiencing a pickup in demand from several key semiconductor customers, reflecting improving global PC demand and continued strength in the Internet-of-Things and automotive end markets. For the fiscal 2017 year we project consolidated adjusted EBITDA of $47-49 million, driven by higher sales in both our Electronic Chemicals and Other Chemicals segments as well as our continued focus on enhancing efficiency.”
Consolidated results
Fourth quarter Dollars in thousands, except EPS | | Fiscal 2016 | | | Fiscal 2015 | |
| | As Reported | | | Adjusted | | | As Reported | | | Adjusted | |
| | (GAAP) | | | (non-GAAP)5 | | | (GAAP) | | | (non-GAAP)6 | |
Net sales | | $ | 75,301 | | | $ | 75,301 | | | $ | 75,993 | | | $ | 75,993 | |
Operating income | | | 7,085 | | | | 7,849 | | | | 5,842 | | | | 6,506 | |
Operating margin | | | 9.4 | % | | | 10.4 | % | | | 7.7 | % | | | 8.6 | % |
Net income | | | 3,743 | | | | 4,483 | | | | 3,328 | | | | 3,759 | |
Diluted earnings per share | | $ | 0.31 | | | $ | 0.38 | | | $ | 0.28 | | | $ | 0.32 | |
Full Year Dollars in thousands, except EPS | | Fiscal 2016 | | | Fiscal 2015 | |
| | As Reported | | | Adjusted | | | As Reported | | | Adjusted | |
| | (GAAP) | | | (non-GAAP)7 | | | (GAAP) | | | (non-GAAP)8 | |
Net sales | | $ | 297,978 | | | $ | 297,978 | | | $ | 320,498 | | | $ | 320,498 | |
Operating income | | | 27,571 | | | | 31,218 | | | | 16,589 | | | | 24,023 | |
Operating margin | | | 9.3 | % | | | 10.5 | % | | | 5.2 | % | | | 7.5 | % |
Net income | | | 18,675 | | | | 19,219 | | | | 12,138 | | | | 14,241 | |
Diluted earnings per share | | $ | 1.57 | | | $ | 1.61 | | | $ | 1.03 | | | $ | 1.21 | |
5 | Non-U.S. GAAP measure. See Tables 2 and 2A for reconciliation. |
6 | Non-U.S. GAAP measure. See Tables 2 and 2A for reconciliation. |
7 | Non-U.S. GAAP measure. See Tables 2 and 2A for reconciliation. |
8 | Non-U.S. GAAP measure. See Tables 2 and 2A for reconciliation. |
Phone: 817.761.6100 ● Fax: 817.720.1043
www.kmgchemicals.com ● NYSE: KMG
2
Business segment results
Electronic Chemicals | | | | | | | | |
Fourth Quarter | | Fiscal 2016 | | | Fiscal 2015 | |
Dollars in thousands | | As Reported | | | As Reported | |
| | (GAAP) | | | (GAAP) | |
Net sales | | $ | 66,282 | | | $ | 66,302 | |
Operating income | | | 8,214 | | | | 5,452 | |
Operating margin | | | 12.4 | % | | | 8.2 | % |
For the fourth fiscal quarter, the Electronic Chemicals segment reported:
| · | Sales of $66.3 million, unchanged from fourth quarter of fiscal 2015. Foreign currency translation reduced sales by $450,000 as compared to the prior year period. Excluding the foreign currency impact, sales increased 0.7% due to higher revenue in Asia, partially offset by lower sales volume in North America. |
| · | Operating income of $8.2 million vs. $5.5 million in the same period of fiscal 2015. Operating income and margin improved primarily due to operating efficiencies and lower distribution costs. |
| · | Adjusted EBITDA9 of $11.3 million, compared to $8.4 million last year. |
Electronic Chemicals | | | | | | | | |
Full Year | | Fiscal 2016 | | | Fiscal 2015 | |
Dollars in thousands | | As Reported | | | As Reported | |
| | (GAAP) | | | (GAAP) | |
Net sales | | $ | 261,523 | | | $ | 265,608 | |
Operating income | | | 32,141 | | | | 21,787 | |
Operating margin | | | 12.3 | % | | | 8.2 | % |
For the fiscal 2016 year, the Electronic Chemicals segment reported:
| · | Sales of $261.5 million, down 1.5% from the prior year. The strong U.S. dollar reduced fiscal 2016 sales by $6 million as compared to the prior year. Excluding the impact of foreign currency, sales increased 1% from the prior year due primarily to product volume growth in North America and Asia, including the contribution from NFC. |
9 | Non-U.S. GAAP measure. See Tables 1 and 1A for reconciliation. |
Phone: 817.761.6100 ● Fax: 817.720.1043
www.kmgchemicals.com ● NYSE: KMG
3
| · | Operating income of $32.1 million, an increase of 48% over the prior year. Operating income margin improved due to operating efficiencies and lower distribution costs. |
| · | Adjusted EBITDA10 of $43.9 million, compared to $34.0 million in the prior year. |
Other Chemicals
As of May 1, 2015, the Other Chemicals segment includes the pentachlorophenol (“penta”) business and the industrial lubricants business.
Fourth Quarter | | | | | | | | | | | | |
Dollars in thousands | | Fiscal 2016 | | | Fiscal 2015 | |
| | As Reported | | | As Reported | | | Adjusted | |
| | (GAAP) | | | (GAAP) | | | (non-GAAP) | |
Net sales | | | 9,019 | | | $ | 9,691 | | | $ | 9,691 | |
Operating income | | | 3,210 | | | | 2,279 | | | | 2,342 | |
Operating margin | | | 35.6 | % | | | 23.5 | % | | | 24.2 | % |
For the fourth fiscal quarter, the Other Chemicals segment reported:
| · | Sales of $9.0 million versus $9.7 million in the same period a year ago, reflecting lower sales of both penta and industrial lubricants. |
| · | Operating income of $3.2 million, or 35.6% of sales, compared to $2.3 million, or 23.5% of sales, last year. The increase in operating income and margin was due to improved costs. |
| · | Adjusted EBITDA11 of $3.4 million, up from $2.7 million last year. |
Full Year | | | | | | | | | | | | |
Dollars in thousands | | Fiscal 2016 | | | Fiscal 2015 | |
| | As Reported | | | As Reported | | | Adjusted | |
| | (GAAP) | | | (GAAP) | | | (non-GAAP) | |
Net sales | | | 36,455 | | | $ | 54,820 | | | $ | 54,820 | |
Operating income | | | 12,631 | | | | 8,735 | | | | 8,798 | |
Operating margin | | | 34.6 | % | | | 15.9 | % | | | 16.0 | % |
For the fiscal 2016 year, the Other Chemicals segment reported:
| · | Sales of $36.5 million versus $54.8 million in the same period a year ago. The decrease in sales was due primarily to the divestiture of the creosote product line in |
10 | Non-U.S. GAAP measure. See Tables 1 and 1A for reconciliation. |
11 | Non-U.S. GAAP measure. See Tables 1 and 1A for reconciliation. |
Phone: 817.761.6100 ● Fax: 817.720.1043
www.kmgchemicals.com ● NYSE: KMG
4
January 2015, partially offset by the contribution from the industrial lubricants business.
| · | Operating income of $12.6 million, or 34.6% of sales, compared to $8.7 million, or 15.9% of sales, last year. The increase in operating income and margin was due to the contribution from the industrial lubricants business, the absence of creosote sales and improved costs. |
| · | Adjusted EBITDA12 of $13.7 million, up from $9.3 million last year. |
Fiscal 2017 Outlook
| · | Sales: Fiscal 2017 consolidated net sales are forecast to be approximately $300-305 million. This forecast includes a projected negative foreign currency impact of approximately $4.5 million. |
| · | Adjusted EBITDA: We forecast adjusted EBITDA of $47-49 million. Our fiscal 2017 adjusted EBITDA forecast includes approximately $5 million in stock-based compensation expense and a negative foreign currency impact of approximately $700,000. |
| · | Depreciation and Amortization: Depreciation and amortization expense is forecast to be approximately $15 million. |
| · | Capital Expenditures: Capital expenditures are forecast to be approximately $20 million, including a portion of our planned capital investment in Singapore. |
With respect to the Company’s full year guidance of Adjusted EBITDA, the Company is not able to provide a reconciliation of these fiscal 2017 non-GAAP financial measures to the most comparable GAAP measure without unreasonable efforts; certain items that are included have not yet occurred and cannot be reasonably predicted, and, accordingly, the probable significance of such items cannot be determined at this time. The most comparable GAAP measure and reconciling information that is unavailable, or not reasonably predictable, would include restructuring and realignment charges and acquisition and integration-related expenses.
Conference call
Date: Thursday, October 13, 2016
Time: 5:00 p.m. ET
Dial in: 877.789.6981 or 541.797.2420
Participant passcode: 82043840
The conference call will be webcast live via the “Investors” section of the Company’s website at http://kmgchemicals.com.
12 | Non-U.S. GAAP measure. See Tables 1 and 1A for reconciliation. |
Phone: 817.761.6100 ● Fax: 817.720.1043
www.kmgchemicals.com ● NYSE: KMG
5
If you are unable to listen live, the conference call will be archived on the KMG website. A telephone replay of the call will also be available for one week, starting at 8:00 p.m. ET on October 13, 2016. To access the call, dial 855.859.2056 (domestic) or 404.537.3406 (international) using participant passcode 82043840.
About KMG
KMG Chemicals, Inc., through its subsidiaries, produces and distributes specialty chemicals to select markets. The Company grows by acquiring and optimizing stable chemical product lines and businesses with established production processes. For more information, visit the Company's website at http://kmgchemicals.com.
The information in this news release includes certain forward-looking statements that are based upon assumptions that in the future may prove not to have been accurate and are subject to significant risks and uncertainties, including statements as to the future performance of the company. Although the company believes that the expectations reflected in its forward-looking statements are reasonable, it can give no assurance that such expectations or any of its forward-looking statements will prove to be correct. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, product development acceptance, the impact of competitive services and pricing and general economic risks and uncertainties.
Phone: 817.761.6100 ● Fax: 817.720.1043
www.kmgchemicals.com ● NYSE: KMG
6
KMG CHEMICALS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME
(In thousands, except per share amounts)
| | Three Months Ended | | | Twelve Months Ended | |
| | July 31, | | | July 31, | |
| | 2016 | | | 2015 | | | 2016 | | | 2015 | |
Net sales | | $ | 75,301 | | | $ | 75,993 | | | $ | 297,978 | | | $ | 320,498 | |
Cost of sales | | | 46,444 | | | | 49,477 | | | | 182,470 | | | | 211,021 | |
Gross profit | | | 28,857 | | | | 26,516 | | | | 115,508 | | | | 109,477 | |
| | | | | | | | | | | | | | | | |
Distribution expenses | | | 8,861 | | | | 10,802 | | | | 36,986 | | | | 48,523 | |
Selling, general and administrative expenses | | | 12,680 | | | | 9,297 | | | | 49,192 | | | | 37,461 | |
Restructuring charges | | | 231 | | | | 379 | | | | 1,629 | | | | 1,279 | |
Realignment charges | | | — | | | | 196 | | | | 130 | | | | 5,625 | |
Operating income | | | 7,085 | | | | 5,842 | | | | 27,571 | | | | 16,589 | |
Other income (expense) | | | | | | | | | | | | | | | | |
Interest expense, net | | | (194 | ) | | | (309 | ) | | | (799 | ) | | | (1,407 | ) |
Gain on purchase of NFC | | | (243 | ) | | | — | | | | 1,826 | | | | — | |
Gain on sale of creosote distribution business, net | | | — | | | | — | | | | — | | | | 5,448 | |
Other non-operating expense | | | — | | | | — | | | | — | | | | (1,250 | ) |
Other, net | | | (125 | ) | | | 2 | | | | (368 | ) | | | (496 | ) |
Total other income (expense), net | | | (562 | ) | | | (307 | ) | | | 659 | | | | 2,295 | |
| | | | | | | | | | | | | | | | |
Income before income taxes | | | 6,523 | | | | 5,535 | | | | 28,230 | | | | 18,884 | |
Provision for income taxes | | | (2,780 | ) | | | (2,207 | ) | | | (9,555 | ) | | | (6,746 | ) |
Net income | | $ | 3,743 | | | $ | 3,328 | | | $ | 18,675 | | | $ | 12,138 | |
Earnings per share: | | | | | | | | | | | | | | | | |
Net income per common share basic | | $ | 0.32 | | | $ | 0.28 | | | $ | 1.59 | | | $ | 1.04 | |
Net income per common share diluted | | $ | 0.31 | | | $ | 0.28 | | | $ | 1.57 | | | $ | 1.03 | |
| | | | | | | | | | | | | | | | |
Weighted average shares outstanding: | | | | | | | | | | | | | | | | |
Basic | | | 11,735 | | | | 11,685 | | | | 11,719 | | | | 11,673 | |
Diluted | | | 11,937 | | | | 11,845 | | | | 11,926 | | | | 11,779 | |
Phone: 817.761.6100 ● Fax: 817.720.1043
www.kmgchemicals.com ● NYSE: KMG
7
KMG CHEMICALS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except for share and per share amounts)
| | July 31, | | | July 31, | |
| | 2016 | | | 2015 | |
Assets | | | | | | | | |
Current assets | | | | | | | | |
Cash and cash equivalents | | $ | 12,428 | | | $ | 7,517 | |
Accounts receivable | | | | | | | | |
Trade, net of allowances of $210 at July 31, 2016 and $144 at July 31, 2015 | | | 33,324 | | | | 36,887 | |
Other | | | 5,572 | | | | 3,668 | |
Inventories, net | | | 37,401 | | | | 42,082 | |
Current deferred tax assets | | | — | | | | 2,953 | |
Prepaid expenses and other | | | 6,623 | | | | 3,738 | |
Total current assets | | | 95,348 | | | | 96,845 | |
| | | | | | | | |
Property, plant and equipment, net | | | 79,739 | | | | 80,589 | |
Goodwill | | | 22,228 | | | | 22,408 | |
Intangible assets, net | | | 33,906 | | | | 36,560 | |
Restricted cash | | | 1,000 | | | | 1,000 | |
Other assets, net | | | 4,807 | | | | 4,957 | |
Total assets | | $ | 237,028 | | | $ | 242,359 | |
| | | | | | | | |
Liabilities & stockholders’ equity | | | | | | | | |
Current liabilities | | | | | | | | |
Accounts payable | | $ | 26,418 | | | $ | 35,980 | |
Accrued liabilities | | | 11,252 | | | | 9,602 | |
Employee incentive accrual | | | 5,999 | | | | 4,852 | |
Total current liabilities | | | 43,669 | | | | 50,434 | |
| | | | | | | | |
Long-term debt | | | 35,800 | | | | 53,000 | |
Deferred tax liabilities | | | 9,948 | | | | 13,075 | |
Other long-term liabilities | | | 4,422 | | | | 2,429 | |
Total liabilities | | | 93,839 | | | | 118,938 | |
| | | | | | | | |
Commitments and contingencies | | | | | | | | |
| | | | | | | | |
Stockholders’ equity | | | | | | | | |
Preferred stock, $.01 par value, 10,000,000 shares authorized, none issued | | | — | | | ― | |
Common stock, $.01 par value, 40,000,000 shares authorized, 11,877,282 shares issued and outstanding at July 31, 2016 and 11,690,439 shares issued and outstanding at July 31, 2015 | | | 119 | | | | 117 | |
Additional paid-in capital | | | 36,553 | | | | 31,676 | |
Accumulated other comprehensive loss | | | (12,047 | ) | | | (9,667 | ) |
Retained earnings | | | 118,564 | | | | 101,295 | |
Total stockholders’ equity | | | 143,189 | | | | 123,421 | |
Total liabilities and stockholders’ equity | | $ | 237,028 | | | $ | 242,359 | |
Phone: 817.761.6100 ● Fax: 817.720.1043
www.kmgchemicals.com ● NYSE: KMG
8
KMG CHEMICALS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
| | Twelve Months Ended | |
| | July 31, | |
| | 2016 | | | 2015 | |
Cash flows from operating activities | | | | | | | | |
Net income | | $ | 18,675 | | | $ | 12,138 | |
Adjustments to reconcile net income to net cash provided by operating activities | | | | | | | | |
Depreciation and amortization | | | 14,534 | | | | 13,531 | |
Depreciation related to restructuring and realignment | | | 295 | | | | 5,640 | |
Amortization of loan costs included in interest expense | | | 167 | | | | 153 | |
Stock-based compensation expense | | | 4,836 | | | | 2,766 | |
Allowance for excess and obsolete inventory | | | 173 | | | | 941 | |
Gain on sale of creosote business | | | — | | | | (5,448 | ) |
Gain on NFC acquisition | | | (1,826 | ) | | | — | |
Other | | | 81 | | | | — | |
Deferred income tax expense/(benefit) | | | 258 | | | | (3,532 | ) |
Tax benefit from stock-based awards | | | (43 | ) | | | 23 | |
Changes in operating assets and liabilities, net of effects of acquisition | | | | | | | | |
Accounts receivable — trade | | | 5,154 | | | | 1,265 | |
Accounts receivable — other | | | (1,889 | ) | | | (1,884 | ) |
Inventories | | | 4,348 | | | | (740 | ) |
Other current and noncurrent assets | | | 1,221 | | | | (633 | ) |
Accounts payable | | | (9,226 | ) | | | 1,234 | |
Accrued liabilities and other | | | 4,276 | | | | (7,886 | ) |
Net cash provided by operating activities | | | 41,034 | | | | 17,568 | |
| | | | | | | | |
Cash flows from investing activities | | | | | | | | |
Additions to property, plant and equipment | | | (14,358 | ) | | | (13,821 | ) |
NFC acquisition, net of cash acquired | | | (2,679 | ) | | | — | |
Disposals of property, plant and equipment | | | — | | | | 2,572 | |
Acquisition of industrial lubricants business | | | — | | | | (21,938 | ) |
Proceeds from sale of creosote business | | | — | | | | 14,899 | |
Net cash used in investing activities | | | (17,037 | ) | | | (18,288 | ) |
| | | | | | | | |
Cash flows from financing activities | | | | | | | | |
Net borrowings/(payments) under revolving loan facility | | | — | | | | (40,000 | ) |
Deferred financing costs | | | — | | | | (666 | ) |
Proceeds from borrowings under credit facility | | | 2,800 | | | | 59,100 | |
Net payments under credit facility | | | (20,000 | ) | | | (6,100 | ) |
Principal payments on borrowings on term loan | | | — | | | | (20,000 | ) |
Tax benefit from stock-based awards | | | 43 | | | | (23 | ) |
Payment of dividends | | | (1,406 | ) | | | (1,402 | ) |
Net cash used in financing activities | | | (18,563 | ) | | | (9,091 | ) |
| | | | | | | | |
Effect of exchange rate changes on cash | | | (523 | ) | | | (1,924 | ) |
| | | | | | | | |
Net increase (decrease) in cash and cash equivalents | | | 4,911 | | | | (11,735 | ) |
Cash and cash equivalents at beginning of period | | | 7,517 | | | | 19,252 | |
Cash and cash equivalents at end of period | | $ | 12,428 | | | $ | 7,517 | |
Phone: 817.761.6100 ● Fax: 817.720.1043
www.kmgchemicals.com ● NYSE: KMG
9
Reconciliation of GAAP financial measures to non-GAAP financial measures
KMG provides non-GAAP financial information to complement reported GAAP results. KMG believes that analysis of our financial performance would be enhanced by an understanding of the factors underlying that performance and our judgments about the likelihood that particular factors will repeat. We define adjusted EBITDA as earnings from operations before interest, taxes, depreciation, amortization, acquisition and integration expenses, restructuring and realignment charges and other relevant items.
KMG intends to continue to provide certain non-GAAP financial information and the appropriate reconciliation to GAAP in its financial results. As required by SEC rules, the tables below present a reconciliation of our presented non-GAAP measures to the most directly comparable GAAP measures. These non-GAAP measures should be viewed as a supplement to, and not a substitute for, U.S. GAAP measures of performance.
Table 1
RECONCILIATION OF CONSOLIDATED GAAP NET INCOME TO CONSOLIDATED ADJUSTED EBITDA
(in thousands)
| | Fourth Quarter Fiscal 2016 | | | Twelve Months Ended July 31, 2016 | |
Consolidated GAAP net income | | $ | 3,743 | | | $ | 18,675 | |
Add back (deduct): | | | | | | | | |
Income taxes | | | 2,780 | | | | 9,555 | |
Gain on purchase of NFC | | | 243 | | | | (1,826 | ) |
Interest expense | | | 194 | | | | 799 | |
Depreciation & amortization* | | | 3,927 | | | | 14,829 | |
Acquisition & integration expenses | | | 102 | | | | 335 | |
Restructuring & realignment charges | | | 231 | | | | 1,464 | |
Corporate relocation expense | | | 431 | | | | 1,553 | |
Consolidated adjusted EBITDA | | $ | 11,651 | | | $ | 45,384 | |
*Includes depreciation related to restructuring and realignment included in non-cash restructuring and realignment charges on the statement of cash flows.
| | Fourth Quarter Fiscal 2015 | | | Twelve Months Ended July 31, 2015 | |
Consolidated GAAP net income | | $ | 3,328 | | | $ | 12,138 | |
Add back (deduct): | | | | | | | | |
Income taxes | | | 2,207 | | | | 6,746 | |
Other non-operating expense | | | — | | | | 1,250 | |
Loss (gain) on sale of creosote distribution business | | | — | | | | (5,448 | ) |
Interest expense | | | 309 | | | | 1,407 | |
Depreciation & amortization* | | | 3,580 | | | | 19,171 | |
Acquisition & integration expenses | | | 89 | | | | 530 | |
Restructuring & realignment charges | | | 575 | | | | 1,264 | |
Consolidated adjusted EBITDA | | $ | 10,088 | | | $ | 37,058 | |
*Includes depreciation related to restructuring and realignment included in non-cash restructuring and realignment charges on the statement of cash flows.
Phone: 817.761.6100 ● Fax: 817.720.1043
www.kmgchemicals.com ● NYSE: KMG
10
Table 1A
RECONCILIATION OF OPERATING INCOME TO EBITDA AND ADJUSTED EBITDA
(in thousands)
Note that we do not allocate certain financial statement line items below operating income to our segments; as such, the reconciliations below only reflect the reconciliation of our operating income by segment to our non-GAAP measures.
Fourth Quarter Fiscal 2016 | | Electronic | | | Other | | | | | | | | | |
| | Chemicals | | | Chemicals | | | Corporate | | | Total | |
Operating Income (Loss) | | $ | 8,214 | | | $ | 3,210 | | | $ | (4,339 | ) | | $ | 7,085 | |
Other income (expense) | | | (45 | ) | | | (45 | ) | | | (35 | ) | | | (125 | ) |
Depreciation and amortization | | | 3,170 | | | | 282 | | | | 475 | | | | 3,927 | |
Acquisition & integration expenses | | | — | | | | — | | | | 102 | | | | 102 | |
Restructuring charges* | | | — | | | | — | | | | 231 | | | | 231 | |
Corporate relocation expense | | | — | | | | — | | | | 431 | | | | 431 | |
Adjusted EBITDA | | | 11,339 | | | | 3,447 | | | | (3,135 | ) | | | 11,651 | |
Corporate allocation | | | 2,558 | | | | 799 | | | | (3,357 | ) | | | — | |
Adjusted EBITDA excl. corporate allocation | | $ | 13,897 | | | $ | 4,246 | | | $ | (6,492 | ) | | $ | 11,651 | |
* Excludes depreciation
Twelve Months Ended July 31, 2016 | | Electronic | | | Other | | | | | | | | | |
| | Chemicals | | | Chemicals | | | Corporate | | | Total | |
Operating Income (Loss) | | $ | 32,141 | | | $ | 12,631 | | | $ | (17,201 | ) | | $ | 27,571 | |
Other income (expense) | | | (118 | ) | | | (120 | ) | | | (130 | ) | | | (368 | ) |
Depreciation and amortization | | | 11,830 | | | | 1,150 | | | | 1,849 | | | | 14,829 | |
Acquisition & integration expenses | | | — | | | | — | | | | 335 | | | | 335 | |
Restructuring & realignment charges* | | | — | | | | — | | | | 1,464 | | | | 1,464 | |
Corporate relocation expense | | | — | | | | — | | | | 1,553 | | | | 1,553 | |
Adjusted EBITDA | | | 43,853 | | | | 13,661 | | | | (12,130 | ) | | | 45,384 | |
Corporate allocation | | | 10,337 | | | | 3,371 | | | | (13,708 | ) | | | — | |
Adjusted EBITDA excl. corporate allocation | | $ | 54,190 | | | $ | 17,032 | | | $ | (25,838 | ) | | $ | 45,384 | |
* Excludes depreciation
Phone: 817.761.6100 ● Fax: 817.720.1043
www.kmgchemicals.com ● NYSE: KMG
11
(Table 1A continued)
Fourth Quarter Fiscal 2015 | | Electronic | | | Other | | | | | | | | | |
| | Chemicals | | | Chemicals | | | Corporate | | | Total | |
Operating Income (Loss) | | $ | 5,452 | | | $ | 2,279 | | | $ | (1,889 | ) | | $ | 5,842 | |
Other income (expense) | | | — | | | | — | | | | 2 | | | | 2 | |
Depreciation and amortization | | | 2,946 | | | | 340 | | | | 294 | | | | 3,580 | |
Acquisition & integration expenses | | | — | | | | 63 | | | | 26 | | | | 89 | |
Restructuring & realignment charges* | | | — | | | | — | | | | 575 | | | | 575 | |
Adjusted EBITDA | | | 8,398 | | | | 2,682 | | | | (992 | ) | | | 10,088 | |
Corporate allocation | | | 3,588 | | | | 1,367 | | | | (4,955 | ) | | | — | |
Adjusted EBITDA excl. corporate allocation | | $ | 11,986 | | | $ | 4,049 | | | $ | (5,947 | ) | | $ | 10,088 | |
* Excludes depreciation
Twelve Months Ended July 31, 2015 | | Electronic | | | Other | | | | | | | | | |
| | Chemicals | | | Chemicals | | | Corporate | | | Total | |
Operating Income (Loss) | | $ | 21,787 | | | $ | 8,735 | | | $ | (13,933 | ) | | $ | 16,589 | |
Other income (expense) | | | (76 | ) | | | (90 | ) | | | (330 | ) | | | (496 | ) |
Depreciation and amortization | | | 12,257 | | | | 626 | | | | 6,288 | | | | 19,171 | |
Acquisition & integration expenses | | | — | | | | 63 | | | | 467 | | | | 530 | |
Restructuring & realignment charges* | | | — | | | | — | | | | 1,264 | | | | 1,264 | |
Adjusted EBITDA | | | 33,968 | | | | 9,334 | | | | (6,244 | ) | | | 37,058 | |
Corporate allocation | | | 10,780 | | | | 4,071 | | | | (14,851 | ) | | | — | |
Adjusted EBITDA excl. corporate allocation | | $ | 44,748 | | | $ | 13,405 | | | $ | (21,095 | ) | | $ | 37,058 | |
* Excludes depreciation
Table 2
RECONCILIATION OF NET INCOME TO ADJUSTED NET INCOME AND
ADJUSTED DILUTED EARNINGS PER SHARE
(in thousands)
| | Three Months Ended | | | Twelve Months Ended | |
| | July 31, | | | July 31, | |
| | 2016 | | | 2015 | | | 2016 | | | 2015 | |
Net income | | $ | 3,743 | | | $ | 3,328 | | | $ | 18,675 | | | $ | 12,138 | |
Items impacting pre-tax income | | | | | | | | | | | | | | | | |
Restructuring & realignment charges | | | 231 | | | | 575 | | | | 1,759 | | | | 6,904 | |
Acquisition & integration expenses | | | 102 | | | | 89 | | | | 335 | | | | 530 | |
Corporate relocation expense | | | 431 | | | | — | | | | 1,553 | | | | — | |
Gain on purchase of NFC | | | 243 | | | | — | | | | (1,826 | ) | | | — | |
Gain on sale of creosote business | | | — | | | | — | | | | — | | | | (5,448 | ) |
Environmental site cleanup reserve | | | — | | | | — | | | | — | | | | 1,250 | |
Income taxes* | | | (267 | ) | | | (233 | ) | | | (1,277 | ) | | | (1,133 | ) |
Adjusted net income | | $ | 4,483 | | | $ | 3,759 | | | $ | 19,219 | | | $ | 14,241 | |
Adjusted diluted earnings per share | | $ | 0.38 | | | $ | 0.32 | | | $ | 1.61 | | | $ | 1.21 | |
Weighted average diluted shares outstanding | | | 11,937 | | | | 11,845 | | | | 11,926 | | | | 11,779 | |
*Represents the aggregate tax-effect of the items impacting pre-tax income utilizing a tax rate of 35%, except for the gain on the purchase of NFC, which is not a recognized gain for tax purposes.
Phone: 817.761.6100 ● Fax: 817.720.1043
www.kmgchemicals.com ● NYSE: KMG
12
Table 2A
RECONCILIATION OF GAAP FINANCIAL MEASURES TO NON-GAAP FINANCIAL MEASURES
Fourth Quarter Fiscal 2016 | | KMG Chemicals, Inc. | |
Dollars in thousands, except EPS | | | | | | | | | | | | | | | | |
| | Operating | | | Net | | | Diluted Earnings | |
| | Income | | | Margin | | | Income | | | Per Share | |
GAAP measure | | $ | 7,085 | | | | 9.4 | % | | $ | 3,743 | | | $ | 0.31 | |
Acquisition & integration expenses | | | 102 | | | | 0.1 | % | | | 66 | | | | 0.01 | |
Restructuring charges | | | 231 | | | | 0.3 | % | | | 150 | | | | 0.01 | |
Gain on purchase of NFC | | | — | | | | 0.0 | % | | | 243 | | | | 0.02 | |
Corporate relocation expense | | | 431 | | | | 0.6 | % | | | 281 | | | | 0.03 | |
Non-GAAP measure | | $ | 7,849 | | | | 10.4 | % | | $ | 4,483 | | | $ | 0.38 | |
Twelve Months Ended July 31, 2016 | | KMG Chemicals, Inc. | |
Dollars in thousands, except EPS | | | | | | | | | | | | | | | | |
| | Operating | | | Net | | | Diluted Earnings | |
| | Income | | | Margin | | | Income | | | Per Share | |
GAAP measure | | $ | 27,571 | | | | 9.3 | % | | $ | 18,675 | | | $ | 1.57 | |
Acquisition & integration expenses | | | 335 | | | | 0.1 | % | | | 218 | | | | 0.02 | |
Restructuring & realignment charges | | | 1,759 | | | | 0.6 | % | | | 1,143 | | | | 0.09 | |
Gain on purchase of NFC | | | — | | | | 0.0 | % | | | (1,826 | ) | | | (0.15 | ) |
Corporate relocation expense | | | 1,553 | | | | 0.5 | % | | | 1,009 | | | | 0.08 | |
Non-GAAP measure | | $ | 31,218 | | | | 10.5 | % | | $ | 19,219 | | | $ | 1.61 | |
Fourth Quarter Fiscal 2015 | | KMG Chemicals, Inc. | |
Dollars in thousands, except EPS | | | | | | | | | | | | | | | | |
| | Operating | | | Net | | | Diluted Earnings | |
| | Income | | | Margin | | | Income | | | Per Share | |
GAAP measure | | $ | 5,842 | | | | 7.7 | % | | $ | 3,328 | | | $ | 0.28 | |
Restructuring & realignment charges | | | 575 | | | | 0.8 | % | | | 374 | | | | 0.03 | |
Acquisition & integration expenses | | | 89 | | | | 0.1 | % | | | 57 | | | | 0.01 | |
Non-GAAP measure | | $ | 6,506 | | | | 8.6 | % | | $ | 3,759 | | | $ | 0.32 | |
| | Electronic Chemicals | | | Other Chemicals | |
| | Operating | | | Operating | |
| | Income | | | Margin | | | Income | | | Margin | |
GAAP measure | | $ | 5,452 | | | | 8.2 | % | | $ | 2,279 | | | | 23.5 | % |
Acquisition & integration expenses | | | — | | | | — | | | | 63 | | | | 0.7 | % |
Non-GAAP measure | | $ | 5,452 | | | | 8.2 | % | | $ | 2,342 | | | | 24.2 | % |
Twelve Months Ended July 31, 2015 | | KMG Chemicals, Inc. | |
Dollars in thousands, except EPS | | | | | | | | | | | | | | | | |
| | Operating | | | Net | | | Diluted Earnings | |
| | Income | | | Margin | | | Income | | | Per Share | |
GAAP measure | | $ | 16,589 | | | | 5.2 | % | | $ | 12,138 | | | $ | 1.03 | |
Restructuring & realignment charges | | | 6,904 | | | | 2.1 | % | | | 4,488 | | | | 0.38 | |
Acquisition & integration expenses | | | 530 | | | | 0.2 | % | | | 344 | | | | 0.03 | |
Gain on sale of creosote business | | | — | | | | 0.0 | % | | | (3,541 | ) | | | (0.30 | ) |
Environmental site cleanup reserve | | | — | | | | 0.0 | % | | | 812 | | | | 0.07 | |
Non-GAAP measure | | $ | 24,023 | | | | 7.5 | % | | $ | 14,241 | | | $ | 1.21 | |
Phone: 817.761.6100 ● Fax: 817.720.1043
www.kmgchemicals.com ● NYSE: KMG
13
(Table 2A continued)
| | Electronic Chemicals | | | Other Chemicals | |
| | Operating | | | Operating | |
| | Income | | | Margin | | | Income | | | Margin | |
GAAP measure | | $ | 21,787 | | | | 8.2 | % | | $ | 8,735 | | | | 15.9 | % |
Acquisition & integration expenses | | | — | | | | — | | | | 63 | | | | 0.1 | % |
Non-GAAP measure | | $ | 21,787 | | | | 8.2 | % | | $ | 8,798 | | | | 16.0 | % |
KMG Investor Relations
Eric Glover, 817.761.6006
eglover@kmgchemicals.com
Phone: 817.761.6100 ● Fax: 817.720.1043
www.kmgchemicals.com ● NYSE: KMG
14